1-6 of 6
drug inverse agonism
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

352-OR: Regulation of Melanocortin Receptor 4 (MC4R) Ciliary Trafficking

MAXENCE NACHURY
Journal: Diabetes
Diabetes 2023;72(Supplement_1):352-OR
https://doi.org/10.2337/db23-352-OR
Published: 20 June 2023
View article titled, 352-OR: Regulation of Melanocortin Receptor 4 (MC4R) Ciliary Trafficking
Meeting Abstracts

392-P: Phase 1, Randomized, Controlled Trial of GFB-024, a Once-Monthly CB1 Inverse Agonist, in Healthy Overweight and Obese Participants and in Participants with Type 2 Diabetes Mellitus

GREGORY GAICH, SANELA BILIC, YOSSI DAGON, THOMAS GUSTAFSON, JOHN LAWLER, LESLIE JOHNSON, LORI RUDOLPH-OWEN
Journal: Diabetes
Diabetes 2022;71(Supplement_1):392-P
https://doi.org/10.2337/db22-392-P
Published: 01 June 2022
View article titled, 392-P: Phase 1, Randomized, Controlled Trial of GFB-024, a Once-Monthly CB1 Inverse Agonist, in Healthy Overweight and Obese Participants and in Participants with Type 2 Diabetes Mellitus
Meeting Abstracts

208-LB: Peripheral CB1 Inverse Agonism Improves Metabolism in DIO Mice Independent of Hepatic FGF21

JIE LIU
Journal: Diabetes
Diabetes 2021;70(Supplement_1):208-LB
https://doi.org/10.2337/db21-208-LB
Published: 01 June 2021
View article titled, 208-LB: Peripheral CB1 Inverse Agonism Improves Metabolism in DIO Mice Independent of Hepatic FGF21
Journal Articles

Acyl-Ghrelin Influences Pancreatic β-Cell Function by Interference with KATP Channels

Julia Kaiser, Peter Krippeit-Drews, Gisela Drews
Journal: Diabetes
Diabetes 2021;70(2):423–435
https://doi.org/10.2337/db20-0231
Published: 05 November 2020
View article titled, Acyl-Ghrelin Influences Pancreatic β-Cell Function by Interference with K<sub>ATP</sub> Channels
Open the PDF for Acyl-Ghrelin Influences Pancreatic β-Cell Function by Interference with K<sub>ATP</sub> Channels in another window
Journal Articles

Inverse Agonist of Nuclear Receptor ERRγ Mediates Antidiabetic Effect Through Inhibition of Hepatic Gluconeogenesis

Don-Kyu Kim, Gil-Tae Gang, Dongryeol Ryu, Minseob Koh, Yo-Na Kim, Su Sung Kim, Jinyoung Park, Yong-Hoon Kim, Taebo Sim, In-Kyu Lee, Cheol Soo Choi, Seung Bum Park, Chul-Ho Lee, Seung-Hoi Koo, Hueng-Sik Choi
Journal: Diabetes
Diabetes 2013;62(9):3093–3102
https://doi.org/10.2337/db12-0946
Published: 15 August 2013
View article titled, Inverse Agonist of Nuclear Receptor ERRγ Mediates Antidiabetic Effect Through Inhibition of Hepatic Gluconeogenesis
Open the PDF for Inverse Agonist of Nuclear Receptor ERRγ Mediates Antidiabetic Effect Through Inhibition of Hepatic Gluconeogenesis in another window
Includes: Supplementary data
Journal Articles

Regulation of MAP Kinase–Directed Mitogenic and Protein Kinase B–Mediated Signaling by Cannabinoid Receptor Type 1 in Skeletal Muscle Cells

Christopher Lipina, Clare Stretton, Simon Hastings, Jonathan S. Hundal, Ken Mackie, Andrew J. Irving, Harinder S. Hundal
Journal: Diabetes
Diabetes 2010;59(2):375–385
https://doi.org/10.2337/db09-0979
Published: 23 November 2009
View article titled, Regulation of MAP Kinase–Directed Mitogenic and Protein Kinase B–Mediated Signaling by Cannabinoid Receptor Type 1 in Skeletal Muscle Cells
Open the PDF for Regulation of MAP Kinase–Directed Mitogenic and Protein Kinase B–Mediated Signaling by Cannabinoid Receptor Type 1 in Skeletal Muscle Cells in another window